The COL5A1 gene, ultra-marathon running performance, and range of motion

Department of Human Biology, University of Cape Town, Cape Town, South Africa.
International journal of sports physiology and performance (Impact Factor: 2.68). 07/2011; 6(4):485-96.
Source: PubMed

ABSTRACT Endurance running performance is a multifactorial phenotype that is strongly associated with running economy. Sit and reach range of motion (SR ROM) is negatively associated with running economy, suggesting that reduced SR ROM is advantageous for endurance running performance. The COL5A1 gene has been associated with both endurance running performance and SR ROM in separate cohorts. The aim of this study was to investigate whether COL5A1 is associated with ultra-marathon running performance and whether this relationship could be partly explained by prerace SR ROM.
Seventy-two runners (52 male, 20 female) were recruited from the 56 km Two Oceans ultra-marathon and were assessed for prerace SR ROM. The cohort was genotyped for the COL5A1 BstUI restriction fragment length polymorphism, and race times were collected after the event.
Participants with a TT genotype (341 ± 41 min, N = 21) completed the 56 km Two Oceans ultra-marathon significantly (P = 0.014) faster than participants with TC and CC genotypes (365 ± 39 min, N = 50). The COL5A1 genotype and age accounted for 19% of performance variance. When the cohort was divided into performance and flexibility quadrants, the T allele was significantly (P = 0.044) over-represented within the fast and inflexible quadrant.
The COL5A1 genotype was found to be significantly associated with performance in a 56 km ultra-endurance run. This study confirms previous findings and it furthers our understanding of the relationships among ROM, COL5A1, and endurance running performance. We continue to speculate that the COL5A1 gene alters muscle-tendon stiffness.

Download full-text


Available from: Malcolm Collins, Jun 04, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: COL5A1 encodes the α1 chain of type V collagen, a quantitatively minor fibrillar collagen that regulates fibrillogenesis. A variant within the 3'-UTR of COL5A1 is associated with chronic Achilles tendinopathy (AT) and other exercise-related phenotypes but the functional significance of this is unknown. The aim of this study was therefore to identify functional differences between the COL5A1 3'-UTR from patients with AT and asymptomatic controls. To this end we have used a reporter assay in which the COL5A1 3'-UTR from AT patients and controls were cloned downstream of the firefly luciferase gene and luciferase activity measured as an indication of mRNA stability. When the cloned COL5A13'-UTRs were sequenced, two major forms named C- and T-alleles were predominantly identified in the controls and the AT subjects respectively. The luciferase activity of the C-alleles was significantly lower than that of the T-alleles (69.0±22.0% (N=24) vs. 90.6±13.7% (N=30), p<0.001) which suggests an overall increase in mRNA stability for the T-allele. Furthermore, we identified a functional miRNA site for Hsa-miR-608 within the COL5A1 3'-UTR and using deletion constructs we have identified additional elements which regulate COL5A1 mRNA stability. These results have important implications for our understanding of the molecular basis of musculoskeletal soft tissue injuries and other exercise-related phenotypes.
    Matrix biology: journal of the International Society for Matrix Biology 05/2011; 30(5-6):338-45. DOI:10.1016/j.matbio.2011.05.001 · 3.65 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: COLLINS, M. and M. POSTHUMUS. Type V collagen genotype and exercise-related phenotype relationships: a novel hypothesis. Exerc. Sport Sci. Rev., Vol. 39, No. 4, pp. 191-198, 2011. We have shown that a variant within COL5A1, which encodes a subunit of type V collagen, is associated with injury and performance phenotypes. Although seemingly unrelated, these phenotypes are associated directly or indirectly with the mechanical properties of musculoskeletal soft tissue. We therefore hypothesize that variants in the COL5A1 gene alter fibril architecture and structure and, thereby, mechanical properties.
    Exercise and sport sciences reviews 06/2011; 39(4):191-8. DOI:10.1097/JES.0b013e318224e853 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE:: The authors hypothesize that variants within genes, such as COL5A1, COL3A1, COL6A1, and COL12A1, that code for connective tissue components of the musculoskeletal system may modulate susceptibility to exercise-associated muscle cramping (EAMC). Specifically, the aim of this study was to investigate if the COL5A1 rs12722 (C/T), COL3A1 rs1800255 (G/A), COL6A1 rs35796750 (T/C), and COL12A1 rs970547 (A/G) polymorphisms are associated with a history of EAMC. DESIGN:: Retrospective genetic case-control association study. SETTING:: Participants were recruited at triathlon and ultra-marathon events and were asked to report physical activity, medical history, and cramping history. PARTICIPANTS:: One hundred sixteen participants with self-reported history of EAMC within the past 12 months before an ultra-endurance event were included as cases in this study (EAMC group). One hundred fifty participants with no self-reported history of previous (lifelong) EAMC were included as controls (NON group). INTERVENTIONS:: All participants were genotyped for the selected variants. MAIN OUTCOME MEASURES:: Differences in genotype frequency distributions, for COL5A1 rs12722, COL3A1 rs1800255, COL6A1 rs35796750, and COL12A1 rs970547, among the cases and controls. RESULTS:: The COL5A1 CC genotype was significantly overrepresented (P = 0.031) among the NON group (21.8%) when compared with the EAMC group (11.1%). No significant genotype differences were found for the COL3A1 (P = 0.828), COL6A1 (P = 0.300), or COL12A1 (P = 0.120) genotypes between the EAMC and NON groups. CONCLUSIONS:: This study identified, for the first time, the COL5A1 gene as a potential marker for a history of EAMC.
    Clinical journal of sport medicine: official journal of the Canadian Academy of Sport Medicine 08/2012; 23(1). DOI:10.1097/JSM.0b013e3182686aa7 · 2.01 Impact Factor
Show more